Assessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer Patients
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DIAGNOSTIC_TEST: PAM 50 test
Sponsor: Centre Jean Perrin
Collaborators: Roche Pharma AG|NanoString Technologies, Inc.